Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Spirax Group H1 results fall short of expectations

(Sharecast News) - Industrial and commercial steam system products manufacturer Spirax Group fell short of market expectations with its first-half performance but said on Thursday that H2 would be stronger. Spirax said statutory revenues fell 3% year-on-year to £850.8m in the six months ended 30 June due to a "weak macroeconomic environment" in some of its key markets and strong currency headwinds.

Pre-tax profits rose 9% to £124.8m on a statutory basis as operating profit margins improved 230 basis points to 17.8%. Statutory basic earnings per share were up 10% at 123.8p.

However, adjusted pre-tax profits were down 10% at £137.9m and adjusted basic earnings per share shed 12% to 137.2p.

Chief executive Nimesh Patel said: "Against the backdrop of a weak macroeconomic environment in some of our key markets and a strong currency headwind, first half results were slightly below our expectations. We expect stronger growth in the second half, supported by higher IP, ongoing operational improvement in ETS and cost discipline. While we have seen early signs of improving Biopharm demand, we do not anticipate a meaningful recovery until late 2024."

As of 0840 BST, Spirax shares were down 7.03% at 7,935.00p.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Berenberg lowers target price on Impax Asset Management
(Sharecast News) - Analysts at Berenberg lowered their target price on Impax Asset Management from 620.0p to 560.0p on Tuesday but noted that outflows had started to slow.
GSK's Arexvy provides protection over three RSV seasons, trial shows
(Sharecast News) - GSK has announced positive results from a phase III trial of its Arexvy RSV vaccine, showing that just one dose of the treatment could help protect older adults at risk of RSV disease over three seasons.
S&U revenue up, profitability a challenge in first half
(Sharecast News) - Motor and property finance specialist S&U reported a mixed first-half financial performance on Tuesday, after group revenue increased 9% year-on-year to £60.4m.
Loungers reports slight slowdown in LFL sales growth
(Sharecast News) - Cosy Club owner Loungers reported a slight slowdown in like-for-like sales growth on Tuesday and a jump in revenue.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.